4//SEC Filing
ORBIMED ADVISORS LLC 4
Accession 0000947871-25-000392
CIK 0001453593other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 7:14 PM ET
Size
10.4 KB
Accession
0000947871-25-000392
Insider Transaction Report
Form 4
Orbimed ROF II LLC
Director10% Owner
Transactions
- Sale
Common Stock
2025-04-10$0.42/sh−56,004,974$23,522,089→ 0 total(indirect: See footnotes) - Sale
Common Stock
2025-04-10$0.42/sh−17,109,618$7,186,040→ 0 total(indirect: See footnotes)
ORBIMED ADVISORS LLC
10% Owner
Transactions
- Sale
Common Stock
2025-04-10$0.42/sh−56,004,974$23,522,089→ 0 total(indirect: See footnotes) - Sale
Common Stock
2025-04-10$0.42/sh−17,109,618$7,186,040→ 0 total(indirect: See footnotes)
Footnotes (3)
- [F1]These securities are held of record by ROS Acquisition Offshore LP ("ROS Acquisition"). OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the investment manager of ROS Acquisition. By virtue of such relationships, OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by ROS Acquisition. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by ROS Acquisition.
- [F2]These securities are held of record by OrbiMed Royalty Opportunities II, LP ("ORO II"). OrbiMed ROF II LLC ("ROF II") is the general partner of ORO II, and OrbiMed Advisors is the managing member of ROF II. By virtue of such relationships, ROF II and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by ORO II. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by ORO II.
- [F3]This report on Form 4 is jointly filed by OrbiMed Advisors and ROF II. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001055951
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 7:14 PM ET
- Size
- 10.4 KB